Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: A longitudinal study

Journal of Psychiatric Research

Volumn 49, Issue 1, 2014, Pages 96-101

  Diniz, Breno Satler ^a   Reynolds, Charles F ^b   Begley, Amy ^b   Dew, Mary Amanda ^b   Anderson, Stewart J ^c   Lotrich, Francis ^b   Erickson, Kirk I ^b,d   Lopez, Oscar ^b   Aizenstein, Howard ^b   Sibille, Etienne L ^b   Butters, Meryl A ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

BDNF; Dementia; Elderly; Late life depression; Mild cognitive impairment,; Pathophysiology

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DONEPEZIL; PLACEBO;

AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LATE LIFE DEPRESSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BDNF; DEMENTIA; ELDERLY; LATE-LIFE DEPRESSION; MILD COGNITIVE IMPAIRMENT,; PATHOPHYSIOLOGY;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MILD COGNITIVE IMPAIRMENT; PIPERIDINES; TIME FACTORS;

EID: 84891146592     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.11.004     Document Type: Article

References (29)

1. Autio H., Mätlik K., Rantamäki T., Lindemann L., Hoener M.C., Chao M., et al. Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology 2011, 61(8):1291-1296. 10.1016/j.neuropharm.2011.07.033.
2. Bhalla R.K., Butters M.A., Becker J.T., Houck P.R., Snitz B.E., Lopez O.L., et al. Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry 2009, 17:308-316. 10.1097/JGP.0b013e318190b8d8.
3. Butters M.A., Young J.B., Lopez O., Aizenstein H.J., Mulsant B.H., Reynolds C.F., et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008, 10(3):345-357.
4. Caraci F., Copani A., Nicoletti F., Drago F. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 2010, 626(1):64-71. 10.1016/j.ejphar.2009.10.022.
5. Diniz B.S., Butters M.A., Albert S.M., Dew M.A. Reynolds 3rd CF. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013, 202:329-335.
6. Diniz B.S., Nunes P.V., Yassuda M.S., Forlenza O.V. Diagnosis of mild cognitive impairment revisited after one year. Preliminary results of a prospective study. Dement Geriatr Cogn Disord 2009, 27(3):224-231. 10.1159/000203346.
7. Diniz B.S., Teixeira A.L., Talib L.L., Mendonca V.A., Gattaz W.F., Forlenza O.V. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry 2010, 11(3):550-555.
8. Diniz B.S., Teixeira A.L. Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med 2011, 13(4):217-222.
9. Doody R.S., Geldmacher D.S., Gordon B., Perdomo C.A., Pratt R.D. Donepezil Study Group. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001, 58(3):427-433.
10. Douillard-Guilloux G., Guilloux J.P., Lewis D.A., Sibille E. Anticipated brain molecular aging in major depression. Am J Geriatr Psychiatry 2013, 21(5):450-460. 10.1016/j.jagp.2013.01.040.
11. Erickson K.I., Prakash R.S., Voss M.W., Chaddock L., Heo S., McLaren M., et al. Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. JNeurosci 2010, 30(15):5368-5375. 10.1523/JNEUROSCI.6251-09.2010.
12. Erkinjuntti T., Kurz A., Gauthier S., Bullock R., Lilienfeld S., Damaraju C.V. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002, 359(9314):1283-1290.
13. Forlenza O.V., Diniz B.S., Teixeira A.L., Ojopi E.B., Talib L.L., Mendonça V.A., et al. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 2010, 11(6):774-780. 10.3109/15622971003797241.
14. Laird N.M., Ware J.H. Random effects models for longitudinal data. Biometrics 1982, 38:963-974.
15. Laske C., Stransky E., Leyhe T., Eschweiler G.W., Maetzler W., Wittorf A., et al. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. JPsychiatr Res 2007, 41(5):387-394.
16. Lee J.G., Shin B.S., You Y.S., Kim J.E., Yoon S.W., Jeon D.W., et al. Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatry Investig 2007, 6(4):299-305. 10.4306/pi.2009.6.4.299.
17. Lee J.G., Shin B.S., You Y.S., Kim J.E., Yoon S.W., Jeon D.W., et al. Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatry Investig 2009, 6(4):299-305. 10.4306/pi.2009.6.4.299.
18. Lee J.S., Potter G.G., Wagner H.R., Welsh-Bohmer K.A., Steffens D.C. Persistent mild cognitive impairment in geriatric depression. Int Psychogeriatr 2007, 19:125-135.
19. Leyhe T., Stransky E., Eschweiler G.W., Buchkremer G., Laske C. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2008, 258(2):124-128.
20. Lu P., Edland S., Teng E., Tingus K., Petersen R., Cummings J., et al. Donepezil delays progression to AD in MCI subjects with depressive symptoms. Neurology 2009, 72(24):2115-2121.
21. McKinney B.C., Sibille E. The age-by-disease interaction hypothesis of late-life depression. Am J Geriatr Psychiatry 2013, 21(5):418-432. 10.1016/j.jagp.2013.01.053.
22. Murer M.G., Boissiere F., Yan Q., Hunot S., Villares J., Faucheux B., et al. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 1999, 88(4):1015-1032.
23. Pei Y., Smith A.K., Wang Y., Pan Y., Yang J., Chen Q., et al. The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2012, 159B(5):560-566. 10.1002/ajmg.b.32062.
24. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. NEngl J Med 2005, 352(23):2379-2388.
25. Reynolds C.F., Butters M.A., Lopez O., Pollock B.G., Dew M.A., Mulsant B.H., et al. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry 2011, 68(1):51-60.
26. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008, 64(6):527-532. 10.1016/j.biopsych.2008.05.005.
27. Tapia-Arancibia L., Aliaga E., Silhol M., Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res Rev 2008, 59(1):201-220.
28. Taylor W.D., Züchner S., McQuoid D.R., Payne M.E., MacFall J.R., Steffens D.C., et al. The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression. Am J Geriatr Psychiatry 2008, 16(4):263-271. 10.1097/JGP.0b013e3181591c30.
29. Teixeira A.L., Barbosa I.G., Diniz B.S., Kummer A. Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med 2010, 4(6):871-887.